Financial statements Bioavlee
Balance sheet data of BIOAVLEE
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 4 493 107,24 | 4 570 028,98 | 3 488 255,06 | 3 608 284,82 | 3 348 440,11 | 3 272 802,80 |
| A. Fixed assets | 3 799 438,41 | 4 149 622,18 | 3 247 881,70 | 3 143 568,68 | 3 139 268,94 | 3 122 794,85 |
| B. Current assets | 693 668,83 | 420 406,80 | 240 373,36 | 464 716,14 | 209 171,17 | 150 007,95 |
| C. Share capital contributions (basic funds) | 0,00 | - | - | - | - | - |
| D. Own shares (stocks) | 0,00 | - | - | - | - | - |
| Total liabilities | 4 493 107,24 | 4 570 028,98 | 3 488 255,06 | 3 608 284,82 | 3 348 440,11 | 3 272 802,80 |
| A. Equity | 3 056 137,77 | 1 903 980,36 | 2 460 948,07 | 2 669 104,01 | 2 397 574,61 | 2 345 785,23 |
| B. Liabilities and provisions for liabilities | 1 436 969,47 | 2 666 048,62 | 1 027 306,99 | 939 180,81 | 950 865,50 | 927 017,57 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 406 816,14 | 1 433 059,13 | 96 847,90 | 27 540,48 | 43 929,79 | 20 081,86 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.